Systematic review demonstrates that higher dietary polyunsaturated to saturated fat ratios reduce LDL-cholesterol in healthy adults, highlighting the importance of fat type in dietary guidelines.
Dietary guidelines recommend limiting saturated fat (SFA) intake by replacing SFA with polyunsaturated fats (PUFA). PUFA and SFA have opposing effects on LDL-cholesterol (LDL-C) and therefore the dietary ratio of PUFA to SFA (P:S) may be a better indicator of LDL-C response than SFA alone. A systematic review and meta-analysis of randomized clinical trials was conducted to examine LDL-C responses to higher P:S ratio diets compared to isoenergetic, total fat-matched diets with lower P:S ratios in healthy adults. A systematic search of PubMed, Cochrane Central, and Web of Science was conducted. Randomized complete feeding trials lasting ≥3 weeks including two test diets with P:S ratios differing by >0.3 that were matched for energy, fiber, and total fat were included. Random effects meta-analysis was used to evaluate the mean difference (MD) in LDL-C with higher P:S ratio diets compared to lower P:S ratio diets. Heterogeneity in the effect of the P:S ratio by SFA content of the test diets was also evaluated. In total, 1001 publications were identified, and 24 publications reporting 24 trials (n=1011) were eligible. Higher P:S ratio diets (median P:S ratio 1.2; PUFA 10.6%kcal; SFA 8.0%kcal; MUFA 12.6%kcal) lowered LDL-C (MD -9.84 mg/dL; 95%CI -13.65, -6.04; I2=79%) compared to lower P:S ratio diets (median P:S ratio 0.4; PUFA 4.4%kcal; SFA 12.5%kcal; MUFA 14.6%kcal). Heterogeneity in the P:S ratio effect was observed by the test diet SFA content (p<0.001). Higher versus lower P:S ratio diets lowered LDL-C (MD -15.72 mg/dL; 95%CI -20.51, -10.92; I2=68%) when the test diets differed in SFA (≥2%kcal), but not when diets were SFA matched (MD -3.45 mg/dL; 95%CI -7.88, 0.98; I2=70%). Compared to lower P:S ratio diets, higher P:S ratio diets were associated with greater LDL-C reductions in generally healthy adults, and this effect was stronger when PUFA replaced SFA. Prospective Register of Systematic Reviews (PROSPERO) registration number: CRD42023452550.
No takes yet. Share an insight, caveat, or question.
Hart et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: